C21 Reports Q2 Revenue Up 14% QoQ, South Reno Cannabis Dispensary Sees 53% Sales Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 15 2024
0mins
Should l Buy ?
Source: Benzinga
Financial Performance: C21 Investments Inc. reported a revenue of $7.5 million for Q2 2024, marking a 14% increase from the previous quarter, with gross margins rising to 43.5% and positive adjusted EBITDA of $1.3 million.
Dispensary Success: The new South Reno dispensary saw a significant sales increase of 53% in its first quarter, generating $416,000 in September and continuing to grow with $475,000 in October.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
